Transtympanic sodium thiosulphate to prevent cisplatin-related hearing loss: a protocol for randomised controlled multicentre phase III trial, the SOUND trial
Authors
Alex E. Hoetink (ORCID: https://orcid.org/0000-0002-7417-5546)
F. L. J. Cals (ORCID: https://orcid.org/0000-0003-2092-2793)
Transtympanic sodium thiosulphate to prevent cisplatin-related hearing loss: a protocol for randomised controlled multicentre phase III trial, the SOUND trial
Alex E. Hoetink, F. L. J. Cals, Leonie Exterkate, Michael Hauptmann et al.
Journal
BMJ Open
Topics
Hearing, Cochlea, Tinnitus, Genetics
article
Transtympanic sodium thiosulphate to prevent cisplatin-related hearing loss: a protocol for randomised controlled multicentre phase III trial, the SOUND trial
Alex E. Hoetink, F. L. J. Cals, Leonie Exterkate, Michael Hauptmann, Charlotte L. Zuur, Stijn Keereweer, Klaske E. van Sluis, Jan Paul de Boer, Tjasse D. Bruintjes, Robert J. Stokroos, Charlotte W. Duinkerken, Bastiaan Nuijen, Anouk V. M. Burger, Jeroen C. Jansen, Lilly‐Ann van der Velden
article en
Abstract
No abstract available for this paper.
Publication Tag
BMJ OpenVol. 15(12)
Institutions
Radboud University Nijmegen (NL), Leiden University Medical Center (NL), Gelre Hospitals (NL), Erasmus MC (NL), Radboud University Medical Center (NL), The Netherlands Cancer Institute (NL), University Medical Center Utrecht (NL), Medisch Centrum Haaglanden (NL), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NL), Medizinische Hochschule Brandenburg Theodor Fontane (DE), Erasmus University Rotterdam (NL)
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Transtympanic sodium thiosulphate to prevent cisplatin-related hearing loss: a protocol for randomised controlled multicentre phase III trial, the SOUND trial — Alex E. Hoetink, F. L. J. Cals, et al. · BMJ Open (2025) | TGRS Research Map | TGRS